期刊文献+

小鼠脾脏来源树突状细胞的体外扩增培养(英文) 被引量:1

In vitro amplification and culture of mouse spleen derived dendritic cells
下载PDF
导出
摘要 目的:对体外诱导小鼠脾脏单个核细胞分化成的树突状细胞(DC)的生物学表型及功能进行检测,并与骨髓来源的DC进行比较。方法:分离小鼠脾脏单个核细胞,在体外培养的条件下通过添加25 ng.ml-1的粒-单核细胞集落刺激因子和25 ng.ml-1的白细胞介素-4(IL-4)将其诱导为DC,分别从细胞形态、表型以及功能3个方面对其进行检测,并与骨髓来源的DC进行比较。结果:小鼠脾脏来源的DC经磷酸脂多糖(LPS)刺激成熟后其表面显示出明显的树枝状突起,高表达CD11c、CD86及MHC-Ⅱ类分子,并具有极强的刺激同种异基因淋巴细胞增殖的能力,其特征与骨髓来源的DC相差无几。结论:小鼠脾脏单个核细胞能够被诱导为具有正常形态、表型、功能的DC,为DC的功能研究以及进一步制备相应的肿瘤疫苗提供又一可靠来源。 Objective: To induce dendritic cells from mouse spleen mononuclear cells in vitro, and to examine the morphology, phenotype and function of the dendritic cells. Methods: Mononuclear cells isolated from mouse spleen cells were induced into dendritic cells in vitro by supplementing 25 ng·ml^-1 GM-CSF and 25 ng·ml^-1 IL-4, and then their morphology, phenotype and function were examined. Results: Mouse spleen derived DCs were induced into mature through exposure to lipopolysaccharide(LPS) and exhibited dramatic veils of cytoplasm and extensive dendrites in their surfaces with high expression of CD11 c, MHC-Ⅱ and CD86. Their capacity to stimulate primary T cell responses in mixed lymphocyte reaction (MLR) increased. The characteristics of mouse spleen derived DCs were similar to those of bone marrow DCs(BM-DCs). Conclusion: Mouse spleen derived mononuclear cells could be induced into DCs with normal morphology, phenotype and function, which provides a new reliable source for the research of DC function and the preparation of corresponding anti-tumor vaccine.
出处 《东南大学学报(医学版)》 CAS 2010年第5期481-484,共4页 Journal of Southeast University(Medical Science Edition)
关键词 脾脏 骨髓 树突状细胞 诱导 小鼠 spleen marrow dendritic cell induce mice
  • 相关文献

参考文献18

  • 1FLEMING J N,HOSTIKKA S L,CHEN E Y,et al.Plasmacytoid dendritic cells and interferon levels are increased in lymphatic malformations[J].Otolaryngol Head Neck Surg,2008,139(5):671-676.
  • 2ZOU G M,MARTINSON J,HU W Y,et al.The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients[J].Cancer Immunol Immunother,2004,53(8):681-689.
  • 3CHAUVIN C,JOSIEN R.Dendritic cells as killers:mechanistic aspects and potential roles[J].Immunol,2008,181:11-16.
  • 4BANCHEREAU J,STEINMAN R M.Dendritic cells and the control of immunity[J].Nature,1998,392:245-252.
  • 5DOMINQUEZ-SOTO A,CORBI A L.Myeloid dendritic cell lectins and their role in immune responses[J].Curr Opin Investig Drugs,2007,8:910-920.
  • 6BRUNO L.Differentiation of dendritic cell subsets from mouse bone marrow[J].Methods Mol Biol,2007,380:47-57.
  • 7OGAWA F,IINUMA H,OKINAGA K.Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced,spleen-derived dendritic cells and tumour cells[J].Scand J Immunol,2004,59:432-439.
  • 8den BROK M H,NIERKENS S,FIGDOR C G,et al.Dendritic cells:tools and targets for antitumor vaccination[J].Expert Rev Vaccines,2005,4:699-710.
  • 9BANCHEREAU J,PALUCKA A K.Dendritic cells as therapeutic vaccines against cancer[J].Nat Rev Immunol,2005,5:296-306.
  • 10GONG J,KOIDO S,CALDERWOOD S K.Cell fusion:from hybridoma to dendritic cell-based vaccine[J].Expert Rev Vaccines,2008,7:1055-1068.

二级参考文献18

  • 1ZHANG Y,JOE G,ZHU J,et al.Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity[J].Blood,2004,103(10):3970-3978.
  • 2DUFFNER U A,MAEDA Y,COOKE K R,et al.Host dendriticcells alone are sufficient to initiate acute graft-versus-host disease[J].J Immunol,2004,172(12):7393-7398.
  • 3MATTE C C,LIU J,CORMIER J,et al.Donor APCs are required for maximal GVHD but not for GVL[J].Nat Med,2004,10(9):987-992.
  • 4GIVER C R,LI J M,HOSSAIN M S,et al.Reconstructing immunity after allogeneic transplantation[J].Immunol Res,2004,29(1-3):269-282.
  • 5GODFREY W R,KRAMPF M R,TAYLOR P A,et al.Ex vivo depletion of alloreactive cells based on CFSE dye dilution,activation antigen selection,and dendritic cell stimulation[J].Blood,2004,103(3):1158-1165.
  • 6SATO K,YAMASHITA N,BABA M,et al.Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells[J].Blood,2003,101(9):3581-3589.
  • 7MACDONALD K P,ROWE V,FILIPPICH C T,et al.Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation[J].Blood,2003,101(5):2033-2042.
  • 8FAGNONI F F,OLIVIERO B,GIORGIANI G,et al.Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation[J].Blood,2004,104(1):281-289.
  • 9CHKLOVSKAIA E,NOWBAKHT P,NISSEN C,et al.Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation:effects of endogenous flt3 ligand[J].Blood,2004,103(10):3860-3868.
  • 10URBINI B,ARPINATI M,BONIFAZI F,et al.Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome,but not with dendritic cell reconstitution after transplant[J].Exp Hematol,2003,31(10):959-965.

同被引文献20

  • 1张罕,吕喆,李冬妹,何秀娟,伍香玲,胡永秀.实时定量PCR分析小鼠树突状细胞TLR4 mRNA表达及地塞米松的调节[J].细胞与分子免疫学杂志,2008,24(3):221-224. 被引量:4
  • 2Reid CD, Stackpoole A,Meager A,et al. Interaction of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow[J]. J Immunol, 1992,149 (8) :2681-2688.
  • 3Sousa R. Dendritic cells in a mature age [J]. Nat Rev Immunol, 2006,6 (6) : 476-483.
  • 4Liu Q, Shu X, Sun A, et al. Plant-derived small molecule albaconol suppresses LPS triggered proinfiammatory cytokine production and antigen presentation of dendritic cells by impairing NF-KB activation[J]. Int Immunopharmacol,200$, 8 : 1103-1111.
  • 5Boes M,Cerny J,Massol R,et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport [ J ]. Nature, 2002,418 : 983-988.
  • 6Ardavin C. Origin,precursors and differentiation of mouse dendritic cells [J]. Nat Rev Immunol,2003,3 (7):582- 590.
  • 7Fleming JN, Hostikka SL, Chen EY,et al. Plasmacytoid dendritic cells and interferon levels are increased in lymphatic malformations [J]. Otolaryngol Head Neck Surg, 2008,139 (5) : 671-676.
  • 8Molavi O,Mahmud A,Hamdy S,et al. Development of a Poly(D,L-lactic-co-glycolic acid)Nanoparticle formulation of STAT3 inhibitor JSI-124:implication for cancer immunotherapy [J]. Mol Pharmaceutics, 2010,7 (2), 364- 374.
  • 9Inaba KM,Romani N,Aya H,et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor [J]. Exp Med, 1992,176 (6) : 1693-1702.
  • 10Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice.I.Morphology, quantition,tissue distribution [J]. Exp Med,1973,137 (5):1142-1162.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部